Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article

AAM. 2016; 5(1-2): 17-23


Observations on Clinical Safety of Chandraprabha Vati-An Ayurvedic Metallo-Herbo Mineral Formulation

AK Tripathi, SD Pandey, JLN SASTRY, Sasibhushan Vedula.

Abstract
Background: Herbomineral formulations are being successfully used in Ayurvedic therapeutics since centuries. Though the preclinical safety of these formulations is established, there have been reports questioning the safety of their metallic contents, especially the presence of heavy metals. As such, it becomes imperative for the contemporary practitioners of Ayurveda to document and publish their observations on the safety of classical herbomineral formulations; as such studies will enable the scientific community to believe traditional systems too as evidence based on account of safety and efficacy.
Aim: The current work was an observational study in effort to document the safety of Chandraprabha Vati with objective
to review and report dose related adverse effects and its safety.
Method: The study data was collected from the hospital software records to survey the prescription patterns in the regular OPD and also to report any untoward affects of Chandraprabha Vati. The dose related adverse effects / safety of Chandraprabha Vati were reviewed and the observations were reported.
Results & Conclusion: There were no serious adverse reactions or toxicity symptoms with Chandraprabha Vati administered orally at doses of 500-1000 mg/ day given over 1 - 4 months.
Conclusion: Chandraprabha Vati, an Ayurvedic metallo-herbo- mineral formulation is safe when administered in prescribed doses.

Key words: Chandraprabha Vati, Heavy metal, Herbomineral, Safety



Similar Articles

A protein-sulfosalicylic acid/boswellic acids @metal-organic framework nanocomposite as anticancer drug delivery system.
Özsoy M, Atiroğlu V, Guney Eskiler G, Atiroğlu A, Deveci Ozkan A, Özacar M
Colloids and surfaces. B, Biointerfaces. 2021; 204(): 111788

Evaluation of the Efficacy and Safety of an eGlycemic Management System in a Community Hospital Setting.
Bouldin MG, Hong B, Setji T, Greenlee J, Cooper A, Thompson J, Capes K
Journal of diabetes science and technology. 2021; 15(2): 236-241

Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.
Pugliese D, Privitera G, Rogai F, Variola A, Viola A, Laterza L, Privitera AC, Allocca M, Bossa F, Cappello M, Daperno M, Lorenzon G, Mazzuoli S, Principi M, Sablich R, Moser L, Ferronato A, Traini S, Tapete G, Bodini G, Di Girolamo M, Grossi L, Mocci G, Ricci C, Saibeni S, Festa S, Spagnuolo R, Cortelezzi CC, Mocciaro F, Rizzello F, Armuzzi A,
United European gastroenterology journal. 2021; 9(1): 102-109

Reduction of Norovirus Surrogates Alone and in Association with Bacteria on Leaf Lettuce and Tomatoes During Application of Aqueous Ozone.
Dawley CR, Lee JA, Gibson KE
Food and environmental virology. 2021; ():

Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination.
Kappos L, Cohan S, Arnold DL, Robinson RR, Holman J, Fam S, Parks B, Xiao S, Castro-Borrero W
Therapeutic advances in neurological disorders. 2021; 14(): 1756286420987941


Full-text options


Add your Article(s) to Indexes
• CiteIndex: Articles & Statistics







Advertisement
American Journal of Diagnostic Imaging

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.